AB1072,18,2422 2. Require persons with incomes of at least 50 percent of the poverty line to pay
23premiums in accordance with par. (c) as a condition of eligibility for Medical
24Assistance under sub. (23).
AB1072,19,2
13. Require as a condition of eligibility for Medical Assistance under sub. (23)
2completion of a health risk assessment.
AB1072,19,53 4. Charge recipients of Medical Assistance under sub. (23) an $8 copayment for
4nonemergency use of the emergency department in accordance with 42 USC 1396o-1
5(e) (1) and 42 CFR 447.54.
AB1072,19,106 5. Disenroll from Medical Assistance under sub. (23) for 6 months any
7individual who does not pay a required premium under subd. 2. and any individual
8who is required under subd. 1. to participate in a community engagement activity but
9who does not participate for 48 aggregate months in the community engagement
10activity.
AB1072,19,1511 (c) 1. Persons who are eligible for the demonstration project under sub. (23) and
12who have monthly household income that exceeds 50 percent of the poverty line shall
13pay a monthly premium amount of $8 per household. A person who is eligible to
14receive an item or service furnished by an Indian health care provider is exempt from
15the premium requirement under this subdivision.
AB1072,19,2116 2. The department may disenroll under par. (b) 5. a person for nonpayment of
17a required monthly premium only at annual eligibility redetermination after
18providing notice and reasonable opportunity for the person to pay. If a person who
19is disenrolled for nonpayment of premiums pays all owed premiums or becomes
20exempt from payment of premiums, he or she may reenroll in Medical Assistance
21under sub. (23).
AB1072,19,2522 3. The department shall reduce the amount of the required household premium
23by up to half for a recipient of Medical Assistance under sub. (23) who does not engage
24in certain behaviors that increase health risks or who attests to actively managing
25certain unhealthy behaviors.
AB1072,20,3
1(d) The department shall comply with any other requirements not specified
2elsewhere in this subsection that are imposed by the federal department of health
3and human services in its approval effective October 31, 2018.
AB1072,20,84 (e) Before December 31, 2023, the demonstration project requirements under
5this subsection may not be withdrawn and the department may not request from the
6federal government withdrawal, suspension, or termination of the demonstration
7project requirements under this subsection unless legislation has been enacted
8specifically allowing for the withdrawal, suspension, or termination.
AB1072,20,109 (f) The department shall comply with all applicable timing in and requirements
10of s. 20.940.
AB1072,15 11Section 15 . 49.79 (9) (d) 1. of the statutes is repealed.
AB1072,16 12Section 16 . 49.79 (9) (d) 2. of the statutes is renumbered 49.79 (9) (d) and
13amended to read:
AB1072,20,1914 49.79 (9) (d) Subject to the promulgation of rules under subd. 1. s. 49.791, the
15department shall screen and, if indicated, test and treat participants in an
16employment and training program under this subsection who are able-bodied adults
17for illegal use of a controlled substance without a valid prescription for the controlled
18substance. Eligibility for an able-bodied adult to participate in an employment and
19training program under this subsection is subject to s. 49.791.
AB1072,17 20Section 17 . 49.791 of the statutes is created to read:
AB1072,20,22 2149.791 Substance abuse screening, testing, and treatment for
22employment and training programs.
(1) Definitions. In this section:
AB1072,20,2323 (a) “Able-bodied adult” has the meaning given in s. 49.79 (1) (am).
AB1072,21,224 (b) “Administering agency” means an administrative agency within the
25executive branch under ch. 15 or an entity that contracts with the state such as a

1single county consortia under s. 49.78 (1r), a multicounty consortia under s. 49.78 (1)
2(br), or a tribal governing body under s. 49.78 (1) (cr).
AB1072,21,73 (c) “Confirmation test” means an analytical procedure used to quantify a
4specific controlled substance or its metabolite in a specimen through a test that is
5different in scientific principle from that of the initial test procedure and capable of
6providing the requisite specificity, sensitivity, and quantitative accuracy to
7positively confirm use of a controlled substance.
AB1072,21,88 (d) “Controlled substance” has the meaning given in s. 49.79 (1) (b).
AB1072,21,109 (e) “Employment and training program” means the food stamp employment
10and training program under s. 49.79 (9).
AB1072,21,1111 (f) “Food stamp program” has the meaning given in s. 49.79 (1) (c).
AB1072,21,1712 (g) “Medical review officer” means a licensed medical provider who is employed
13by or providing services under a contract to a qualified drug testing vendor, has
14knowledge of substance abuse disorders and laboratory testing procedures, and has
15the necessary training and experience to interpret and evaluate an individual's
16positive test result in relation to the individual's medical history and valid
17prescriptions.
AB1072,21,2118 (h) “Metabolite” means a chemical present in the body when a controlled
19substance is being broken down through natural metabolic processes that can be
20detected or measured as a positive indicator that a controlled substance associated
21with the metabolite has been used.
AB1072,21,2522 (i) “Prescription” means a current order for a controlled substance that
23indicates the specific regimen and duration of the order and that is transmitted
24electronically or in writing by an individual authorized in this state to order the
25controlled substance.
AB1072,22,5
1(j) “Qualified drug testing vendor” means a laboratory certified by the federal
2centers for medical and medicaid services under the federal Clinical Laboratory
3Improvement Amendments of 1988 to collect a specimen, carry out laboratory
4analysis of the specimen, store the specimen for a confirmation test if required,
5complete a confirmation test, and provide review by a medical review officer.
AB1072,22,76 (k) “Screening” means completing a questionnaire specified by the department
7regarding an individual's current and prior use of any controlled substance.
AB1072,22,98 (L) “Specimen” means tissue, fluid, or any other product of the human body
9required to be submitted by an individual for testing under this section.
AB1072,22,1510 (m) “Trauma-informed” means operating under the understanding of the
11science of adverse childhood experiences, toxic stress, trauma, and resilience,
12incorporating that understanding into organizational culture, policies, programs,
13and practices, and adhering to trauma-informed principles such as safety,
14trustworthiness and transparency, peer support, collaboration and mutuality,
15empowerment, and cultural, historical, and gender issue recognition.
AB1072,22,2316 (n) “Treatment” means any service that is conducted under clinical supervision
17to assist an individual through the process of recovery from controlled substance
18abuse, including screening, application of approved placement criteria, intake,
19orientation, assessment, individualized treatment planning, intervention,
20individual or group and family counseling, referral, discharge planning, after care
21or continuing care, record keeping, consultation with other professionals regarding
22treatment services, recovery and case management, crisis intervention, education,
23employment, and problem resolution in life skills functioning.
AB1072,23,424 (o) “Treatment program” means a program certified by the department to
25provide treatment for controlled substance abuse as a medically managed inpatient

1service, a medically monitored treatment service, a day treatment service, an
2outpatient treatment service, a transitional residential treatment service, or a
3narcotic treatment service for opiate addiction or, as approved by the department,
4psychosocial rehabilitation services.
AB1072,23,85 (p) “Treatment provider” means a provider of treatment for controlled
6substance abuse certified by the department, a provider certified under s. 440.88, or
7a licensed professional who meets criteria established by the department of safety
8and professional services.
AB1072,23,14 9(2) Notice of requirement. An administering agency shall provide
10information in a format approved by the department to any individual who expresses
11interest in or is referred to participate in an employment and training program to
12explain the requirement for participants in certain employment and training
13programs to undergo screening, testing, and treatment for abuse of controlled
14substances.
AB1072,23,25 15(3) Administering and evaluating a controlled substance abuse screening
16questionnaire.
(a) At the time of application and at annual redetermination for
17eligibility in the food stamp program, an administering agency shall administer to
18any able-bodied adult who is subject to the work requirement under s. 49.79 (10) (a)
19and intends on meeting the work requirement through participation in the
20employment and training program a controlled substance abuse screening
21questionnaire approved by the department, which may include questions related to
22controlled substance abuse-related criminal background and controlled substance
23abuse. The administering agency shall determine whether answers to the controlled
24substance abuse screening questionnaire indicate possible use of a controlled
25substance without a valid prescription by the able-bodied adult.
AB1072,24,4
1(b) 1. An able-bodied adult who is administered a controlled substance abuse
2screening questionnaire under par. (a) shall answer all questions on the screening
3questionnaire, sign and date the questionnaire, and submit the questionnaire to the
4administering agency.
AB1072,24,75 2. If the able-bodied adult indicates on the screening questionnaire submitted
6under subd. 1. the prescribed use of a controlled substance, the able-bodied adult
7shall provide evidence of the valid prescription to the administering agency.
AB1072,24,158 (c) An able-bodied adult who is administered a controlled substance abuse
9screening questionnaire under par. (a) and who fails to comply with the requirements
10under par. (b) is not eligible to participate in the employment and training program,
11and the administering agency may not refer the individual to participate in the
12employment and training program. An able-bodied adult who is denied eligibility
13for participation in the employment and training program for failure to complete the
14requirements under par. (b) may complete the requirements under par. (b) at any
15time while eligible for the food stamp program.
AB1072,24,2016 (d) An able-bodied adult who completes a controlled substance abuse screening
17questionnaire under this subsection and whose answers to the screening
18questionnaire do not indicate possible abuse of a controlled substance has satisfied
19the requirements of this section and may participate in an employment and training
20program subject to this section.
AB1072,25,2 21(4) Testing for use of a controlled substance required. (a) Individuals
22required to undergo testing; exception.
1. Except as provided in subd. 2., an
23administering agency shall require an able-bodied adult whose answers on the
24controlled substance abuse screening questionnaire submitted under sub. (3)

1indicate possible use of a controlled substance without a prescription to undergo a
2test for the use of a controlled substance.
AB1072,25,73 2. An administering agency may not require an able-bodied adult whose
4answers on the controlled substance abuse screening questionnaire submitted under
5sub. (3) indicate possible use of a controlled substance and who also indicates
6readiness to enter treatment for controlled substance abuse to undergo a test for the
7use of a controlled substance.
AB1072,25,148 (b) Nature of testing required. A test for use of a controlled substance under
9this subsection consists of laboratory analysis of a specimen collected from an
10able-bodied adult described in par. (a) in a manner specified by the department that
11is consistent with guidelines from the federal department of health and human
12services by a qualified drug testing vendor or a provider approved by the department.
13The qualified drug testing vendor or other provider shall analyze the specimen for
14the presence of controlled substances specified by the department.
AB1072,25,2015 (c) Contracts for testing services. 1. The administering agency, subject to the
16department's approval, may contract with a trauma-informed qualified drug testing
17vendor to collect a specimen, carry out laboratory analysis of the specimen, store the
18specimen for confirmatory testing if required, complete confirmatory testing, provide
19review by a medical review officer, and document and report test results to the
20administering agency.
AB1072,25,2421 2. The department may require administering agencies to use a specific drug
22testing service procured through state contracting if the department determines that
23volume discounts or other preferential pricing terms may be achieved through a
24statewide contract.
AB1072,26,5
1(d) Effects of refusal to submit to drug test. 1. An able-bodied adult who is
2required to undergo a test for the use of a controlled substance under par. (a) but who
3refuses to submit to a drug test by doing any of the following is ineligible to
4participate in the employment and training program until the individual agrees to
5be tested for use of a controlled substance and test results have been reported:
AB1072,26,66 a. Failing or refusing to appear for a scheduled drug test without good cause.
AB1072,26,107 b. Failing or refusing to complete a form or release of information required for
8testing, including any form or release required by the qualified drug testing vendor
9to permit the vendor to report test results to the administering agency or
10department.
AB1072,26,1111 c. Failing or refusing to provide a valid specimen for testing.
AB1072,26,1212 d. Failing or refusing to provide verification of identity to the testing vendor.
AB1072,26,1613 2. The administering agency may direct an able-bodied adult who initially
14refused to submit to a drug test under subd. 1. and subsequently agrees to submit
15to a test to undergo drug testing on a random basis at any time within 10 business
16days after the able-bodied adult agrees to submit to a test.
AB1072,26,2217 (e) Confirmation test required. If an able-bodied adult tests positive for the use
18of a controlled substance, the qualified drug testing vendor shall perform a
19confirmation test using the same specimen obtained for the initial drug test. The
20vendor's medical review officer who is responsible for determining the presence of a
21controlled substance under par. (b) shall interpret all drug test results that are not
22negative.
AB1072,27,423 (f) Accepting test results from other programs. For purposes of this section, an
24administering agency may use results of a drug test performed by the administering
25agency for the purpose of eligibility for another state program, including a work

1experience program under s. 49.162, 49.36, or 108.133, performed at the request of
2the department of corrections, or performed by other drug testing providers as
3approved by the department to determine whether to refer an able-bodied adult to
4treatment if all of the following apply:
AB1072,27,55 1. The test results are provided directly to the administering agency.
AB1072,27,76 2. The test results include tests for all controlled substances required by the
7department to be tested under this section.
AB1072,27,98 3. The test occurred within 90 days before the results are provided to the
9administering agency.
AB1072,27,1510 (g) Effect of a negative test. An able-bodied adult who undergoes a test for use
11of a controlled substance under this subsection and tests negative for use of a
12controlled substance or who tests positive for use of a controlled substance but
13provides to the administering agency a prescription for each controlled substance for
14which the adult tests positive is not prohibited from participating in an employment
15and training program.
AB1072,27,2116 (h) Effect of a positive test. An able-bodied adult who undergoes a test for use
17of a controlled substance under this subsection, whose test results are positive, and
18who does not provide evidence of a prescription for the controlled substance, as
19determined by the qualified drug testing vendor's medical review officer, is required
20to participate in treatment under sub. (5) to participate in an employment and
21training program.
AB1072,27,25 22(5) Participation in treatment required. (a) Individuals required to
23participate in treatment.
An able-bodied adult who is described under sub. (4) (a)
24or (h) is required to participate in trauma-informed treatment to be eligible to
25participate in an employment and training program.
AB1072,28,7
1(b) Referral for treatment; monitoring. The applicable administering agency
2shall provide to every able-bodied adult who is required to participate in treatment
3under par. (a) information about treatment programs and county-specific
4assessment and enrollment activities required for entry into treatment. The
5applicable administering agency shall monitor the able-bodied adult's progress in
6entering and completing treatment and the results of random testing for the use of
7a controlled substance carried out during and at the conclusion of treatment.
AB1072,28,118 (c) Evaluation and assessment. A treatment provider shall conduct a
9trauma-informed substance abuse evaluation and assessment of each able-bodied
10adult and take any of the following actions, as appropriate, based on the evaluation
11and assessment:
AB1072,28,1412 1. If the treatment provider determines the able-bodied adult does not need
13treatment, notify the administering agency that the able-bodied adult does not need
14treatment.
AB1072,28,1815 2. If the treatment provider determines the able-bodied adult is in need of
16treatment, refer the individual to an appropriate treatment program to begin
17treatment and notify the administering agency of the referral and the expected start
18date and duration of treatment.
AB1072,28,2219 3. If a treatment provider determines the able-bodied adult is in need of
20treatment but is unable to refer the adult because there is a waiting list for
21enrollment, enter the able-bodied adult on the waiting list and notify the
22administering agency of the date the adult is expected to be enrolled.
AB1072,29,223 (d) Eligibility when treatment not needed or on waiting list. 1. An able-bodied
24adult described in par. (c) 1. is determined to have satisfied the requirements of this

1section and is eligible under this section to participate in an employment and
2training program.
AB1072,29,83 2. An able-bodied adult who is on a waiting list for enrollment in an
4appropriate treatment program under par. (c) 3. shall continue to take all necessary
5steps to continue seeking enrollment in the appropriate treatment program. The
6able-bodied adult is eligible under this section to participate in an employment and
7training program while on the waiting list if the adult is not eligible for immediate
8enrollment in another appropriate treatment program.
AB1072,29,149 (e) Satisfying treatment requirement through another program. An
10administering agency shall accept as satisfying the requirements of this subsection
11participation in any treatment program. The able-bodied adult satisfying the
12requirements of this subsection by participating in another treatment program shall
13execute a release of information to allow the administering agency to obtain
14verification of successful participation in that treatment program.
AB1072,29,1915 (f) Effects of refusal to submit to treatment. An able-bodied adult who is
16required to participate in treatment under par. (a) but who refuses to participate in
17treatment by doing any of the following is ineligible to participate in the employment
18and training program until the individual agrees to participate in treatment while
19still eligible for the food stamp program:
AB1072,29,2320 1. Failing or refusing to complete a form or release required for treatment
21program administration, including a form or release required by the treatment
22provider in order to share information with the administering agency about the
23able-bodied adult's participation in treatment.
AB1072,30,224 2. Failing or refusing to participate in a controlled substance test required by
25the treatment provider or the administering agency during the course of required

1treatment, including any random controlled substance testing directed by the
2treatment provider or administering agency.
AB1072,30,43 3. Failing or refusing to meet attendance or participation requirements
4established by the treatment provider.
AB1072,30,55 4. Failing or refusing to complete a substance abuse assessment.
AB1072,30,86 (g) Completion of required treatment. An able-bodied adult required under par.
7(a) to participate in treatment is considered to have successfully completed
8treatment if all applicable components identified under par. (c) are satisfied.
AB1072,30,129 (h) Work requirements while in treatment. An able-bodied adult who is
10participating in an employment and training program is exempt from complying
11with requirements to work a specified number of hours under s. 49.79 (9) or (10) while
12participating in treatment under this subsection.
AB1072,30,15 13(6) Effect of completion, withdrawal, or termination from employment and
14training program.
An able-bodied adult who satisfies any of the following is no
15longer subject to s. 49.79 (9) (d) or this section:
AB1072,30,1716 (a) The able-bodied adult has completed or voluntarily withdrawn from
17participation in an employment and training program.
AB1072,30,1918 (b) The able-bodied adult is terminated from an employment and training
19program for reasons unrelated to this section.
AB1072,30,2120 (c) The able-bodied adult is no longer subject to the requirements of s. 49.79
21(10).
AB1072,31,5 22(7) Confidentiality of records. Completed screening questionnaires,
23prescriptions, testing results, and treatment records relating to this section may not
24be disclosed except for purposes connected with the administration of an
25employment and training program or except when disclosure is otherwise authorized

1by law or by written consent from the individual who is the subject of the record. The
2department may establish administrative, physical, and technical safeguard
3procedures administering agencies must follow to assure compliance with state and
4federal laws related to public assistance program records, drug testing and
5treatment records, and medical records.
AB1072,31,8 6(8) Appeals. An adverse decision under this section may be appealed under 7
7CFR 273.15
and procedures established in rules promulgated by the division of
8hearings and appeals.
AB1072,31,12 9(9) Payment of costs for screening, testing, and treatment. (a) The
10department shall pay for all costs related to screening able-bodied adults under sub.
11(3), including the costs of producing, administering, and reviewing screening
12questionnaires.
AB1072,31,1513 (b) The department shall pay for all costs related to testing able-bodied adults
14under sub. (4), including any costs related to contracting with qualified drug testing
15vendors under sub. (4) (c).
AB1072,31,2016 (c) The department shall pay costs for treatment under sub. (5) that are not
17covered by the Medical Assistance program under subch. IV of ch. 49 or other private
18insurance. Payments by the department under this paragraph shall be at rates no
19higher than the rates paid for comparable services under the Medical Assistance
20program.
AB1072,18 21Section 18. 106.05 (2) (b) (intro.) of the statutes is amended to read:
AB1072,32,222 106.05 (2) (b) (intro.) Subject to par. (c) and sub. (3), from the appropriation
23under s. 20.445 (1) (b) (dr), the department may provide to an apprentice described
24in par. (a) 1. or the apprentice's sponsor a completion award equal to 25 percent of
25the cost of tuition incurred by the apprentice or sponsor or $1,000, whichever is less.

1If the department provides a completion award under this subsection, the
2department shall pay the award as follows:
AB1072,19 3Section 19. 106.05 (3) (a) of the statutes is amended to read:
AB1072,32,104 106.05 (3) (a) If the amount of funds to be distributed under sub. (2) exceeds
5the amount available in the appropriation under s. 20.445 (1) (b) (dr) for completion
6awards under sub. (2), the department may reduce the reimbursement percentage
7or deny applications for completion awards that would otherwise qualify under sub.
8(2). In that case, the department shall determine the reimbursement percentage and
9eligibility on the basis of the dates on which apprentices and sponsors become eligible
10for completion awards.
AB1072,20 11Section 20. 106.13 (3m) (b) (intro.) of the statutes is amended to read:
AB1072,32,2212 106.13 (3m) (b) (intro.) From the appropriation under s. 20.445 (1) (b) (e), the
13department may award grants to applying local partnerships for the implementation
14and coordination of local youth apprenticeship programs. A local partnership shall
15include in its grant application the identity of each public agency, nonprofit
16organization, individual, and other person who is a participant in the local
17partnership, a plan to accomplish the implementation and coordination activities
18specified in subds. 1. to 6., and the identity of a fiscal agent who shall be is responsible
19for receiving, managing, and accounting for the grant moneys received under this
20paragraph. Subject to par. (c), a local partnership that is awarded a grant under this
21paragraph may use the grant moneys awarded for any of the following
22implementation and coordination activities:
AB1072,21 23Section 21. 106.18 of the statutes is amended to read:
AB1072,33,3
1106.18 Youth programs in 1st class cities. From the appropriation account
2under s. 20.445 (1) (b) (fm), the department shall implement and operate youth
3summer jobs programs in 1st class cities.
AB1072,22 4Section 22. 106.26 (3) (c) (intro.) of the statutes is amended to read:
Loading...
Loading...